Lamisil Once

Terbinafine, the active ingredient in Lamisil Once, is an allylamine presented as a topical formulation for skin use. It treats dermatophyte infections such as athlete’s foot, ringworm, and jock itch in both adults and children.

GNH USA supplies Lamisil Once as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Terbinafine acts on dermatophyte fungi, providing antifungal therapy for common skin infections.

- Tinea pedis (athlete’s foot): reduces fungal growth and alleviates itching and scaling. - Tinea corporis (ringworm): clears the rash and prevents spread of infection. - Tinea cruris (jock itch): eliminates the causative fungus and relieves irritation.

Topical terbinafine may cause local and, rarely, systemic adverse reactions.

Common Side Effects: - Burning sensation at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or scaling of the skin. - Stinging or tingling feeling. - Mild irritation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling, hives, or difficulty breathing. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Bullous or severe contact dermatitis. - Systemic toxicity such as liver enzyme elevation (rare with topical use).

Before applying Lamisil Once, consider the following precautions to ensure safe and effective use.

- Avoid application to broken or inflamed skin: may increase systemic absorption. - Do not use concurrently with other topical antifungals without medical advice. - Discontinue if severe local irritation or allergic reaction occurs. - Consult a healthcare professional if you are pregnant, planning pregnancy, or breastfeeding. - Store at room temperature below 25°C: keep in the original pack, protect from moisture and light.

Terbinafine can interact with other medicines or topical agents, influencing its safety profile.

Major Interactions (Avoid): - Concomitant use with systemic terbinafine: risk of increased systemic exposure. - Use with potent CYP450 inhibitors (e.g., ketoconazole) may raise systemic levels if absorbed.

Moderate Interactions (Monitor Closely): - Co‑application with corticosteroid creams may reduce antifungal efficacy. - Use with other skin irritants may increase local reactions. - Concurrent use with other topical agents may affect absorption and tolerability.